Jackson Andrew C. 4
4 · Ra Medical Systems, Inc. · Filed Nov 19, 2020
Insider Transaction Report
Form 4
Jackson Andrew C.
CFO & Secretary
Transactions
- Award
Common Stock
2020-11-17+35,276→ 37,284 total
Footnotes (2)
- [F1]The reported shares were issued as a restricted stock award ("RSA"). 50% of the shares underlying the RSA shall vest and become non-forfeitable as follows: 1/3 of the number of shares will vest on November 20, 2021, and 1/6th of the number of shares will vest on each May 20 and November 20 thereafter, such that 50% of the RSA will be fully vested on November 20, 2023; provided, however, that if a vesting date would otherwise fall on a day when the national stock exchange upon which the shares are listed is not open for trading, vesting will occur on the first trading day thereafter. The remaining 50% of the shares underlying the RSA shall vest and become non-forfeitable upon certain performance milestones being met by November 20, 2021. Vesting in all instances is subject to the reporting person's continuous status as a Service Provider (as defined in the 2018 Equity Incentive Plan) through each vesting date.
- [F2]On November 16, 2020, the common stock of the company reverse-split 25-for-1, resulting in the reporting persons ownership being reduced by 48,194.